DNMT1 and neoplasm: Aberrant DNA methylation in human carcinomas may result from the loss of a CpG island protection factor, mis-targeting of a DNMT complex, and alterations in replication timing. Although aberrant DNA methylation is a vast phenotype in most cancers, identifying the specific alterations riding the tumor phenotype can guide therapeutic strategy [36].